In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 75 for your search:
Cancer Type/Condition:  Colon cancer
Trial Type:  Screening
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Screening
Status: Active
Age: 40 to 65
Sponsor: Other
Protocol IDs: CEC_cribado_CCR, NCT01557101
2.

Phase: Phase IV
Type: Screening
Status: Active
Age: 58 to 60
Sponsor: Other
Protocol IDs: 14334-c27.2, NCT01739608
3.

Phase: Phase III, Phase II
Type: Screening
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 190-CLD-AOS, NCT00867724
4.

Phase: Phase III
Type: Behavioral study, Health services research, Screening
Status: Active
Age: 50 to 74
Sponsor: NCI
Protocol IDs: TJUH-2006-44, 2006-44, NCT00617071
5.

Phase: Phase III
Type: Screening
Status: Active
Age: 50 to 79
Sponsor: NCI
Protocol IDs: TJUH-RSGT-08-017-01-CPPB, RSGT-08-017-01-CPPB, 08G.89, NCT00893295
6.

Phase: Phase III
Type: Screening
Status: Active
Age: 55 to 64
Sponsor: Other
Protocol IDs: NordICC, NCT00883792
7.

Phase: Phase III
Type: Natural history/Epidemiology, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000654114, FFCD-PRODIGE-13, 2009-A00536-51, EU-20979, PRODIGE 13, FFCD 0902, NCT00995202
8.

Phase: Phase III
Type: Diagnostic, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CRE-2011.125-T, NCT01434199
9.

Phase: Phase III
Type: Screening
Status: Active
Age: 50 to 74
Sponsor: Other
Protocol IDs: 10-163, NCT01506687
10.

Phase: Phase III
Type: Screening
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 5130003, LLUMCGI2013, NCT01782014
11.

Phase: Phase II, Phase I
Type: Diagnostic, Screening, Treatment
Status: Approved-not yet active
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSP-IL-LIT-0703_S_01, NCT00715325
12.

Phase: Phase II, Phase I
Type: Screening
Status: Active
Age: 40 to 80
Sponsor: NIDDK
Protocol IDs: 080173, 08-DK-0173, NCT00719641
13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Screening
Status: Active
Age: 50 to 80
Sponsor: NCI
Protocol IDs: NCCTG-GLNE010, GLNE 010, GLNE010, NCT01511653
14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Screening
Status: Active
Age: 40 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: NER1006-01/2012 (OPT), NCT01714466
15.

Phase: Phase II
Type: Screening
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: CD-1158, NCT01549535
16.

Phase: Phase I
Type: Screening
Status: Active
Age: 45 to 80
Sponsor: Other
Protocol IDs: 633, NCT00124163
17.

Phase: Phase I
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 9461701245, NCT00302679
18.

Phase: Phase I
Type: Screening
Status: Approved-not yet active
Age: 50 to 74
Sponsor: NCCAM, NCI, Other
Protocol IDs: 1UH2AT007782-01, NCT01742065
19.

Phase: No phase specified
Type: Screening
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: 9461700610, NCT00173277
20.

Phase: No phase specified
Type: Screening
Status: Active
Age: 50 to 75
Sponsor: NCI, Other
Protocol IDs: 5 R01 HS013912-03, NCT00251862
21.

Phase: No phase specified
Type: Educational/Counseling/Training, Screening
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: 070504, NCT00534053
22.

Phase: No phase specified
Type: Natural history/Epidemiology, Screening, Tissue collection/Repository
Status: Active
Age: 40 to 75
Sponsor: NCI, Other
Protocol IDs: CDR0000583154, VU-VICC-GI-0294, VU-VICC-020603, VU-VICC-020531, VICC-GI-0294, NCT00625066
23.

Phase: No phase specified
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AR0002, 00371, NCT00613262
24.

Phase: No phase specified
Type: Screening, Supportive care
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 200802031R, NCT00745927
25.

Phase: No phase specified
Type: Screening
Status: Active
Age: 30 and over
Sponsor: Other
Protocol IDs: HIC0809004192, NCT00859625
1    
New Search